Product Name: Ubrogepant
Description: Ubrogepant, also known as MK-1602, is a potent and selective oral calcitonin gene-related peptide (CGRP) receptor antagonist. Ubrogepant has completed Phase II clinical trials for acute treatment of migraines.
CAS NO: 108212-75-5 Product: Calicheamicin
Synonym: MK-1602; MK 1602; MK1602; Ubrogepant
IUPAC Chemical Name: (S)-N-((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2-oxo-1,2,5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3-pyrrolo[2,3-b]pyridine]-3-carboxamide
In ChiKey: DDOOFTLHJSMHLN-ZQHRPCGSSA-NMMP inhibitors
SMILE Code: O=C(C1=CN=C2C(C[C@@]3(C4=CC=CN=C4NC3=O)C2)=C1)N[C@@H]5C(N(CC(F)(F)F)[C@H](C)[C@H](C6=CC=CC=C6)C5)=O
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22150089
Chemical Formula：C29H26F3N5O3
ExactMass: 549.1988
Molecular Weight: 549.5542
Elemental Analysis: C, 63.38; H, 4.77; F, 10.37; N, 12.74; O, 8.73
bet-bromodomain.com
BET Bromodomain Inhibitor
